<DOC>
	<DOCNO>NCT02003521</DOCNO>
	<brief_summary>We hypothesize ability Lung Flute enhance mucus clearance low airway could use improve asthma control , device use chronic basis . The primary end point study comparison Asthma Control Test ( ACT ) - validate questionnaire asthma control exhale NO , use lung flute . Several secondary end point assess efficacy safety , include health status , spirometric lung function , `` step '' controller therapy daily albuterol use .</brief_summary>
	<brief_title>Impact Lung Flute Therapy Asthma</brief_title>
	<detailed_description>This 3 month open label study . We plan enroll 48 subject asthma Buffalo General Medical Center Allergy Clinic office Dr. James Cumella . Inclusion criterion include : least 12 year age , diagnosis asthma current previous history smoking . Exclusion criterion include : exacerbation asthma hospitalization asthma within 8 week prior enrollment , predominant chronic obstructive pulmonary disease ( COPD ) bronchiectasis clinical and/or radiological assessment , history cough syncope , pregnant nursing woman , inability comply study procedure .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>least 12 year age diagnosis asthma current previous history smoking . exacerbation asthma hospitalization asthma within 8 week prior enrollment predominant COPD bronchiectasis clinical and/or radiological assessment history cough syncope pregnant nursing woman fluent English inability comply study procedure .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Lung Flute</keyword>
</DOC>